A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases (ENTHUSE M1)

Clinical Trial ID NCT00554229

PubWeight™ 17.04^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00554229

Top papers